Showing results (231-240 of 360) with videos related to

Sort By:
Pageof 36
International Journal of Cancer|October 15, 2013
PI3K/AKT pathway activation in bladder carcinogenesisJulien Calderaro, Sandra Rebouissou, Leanne de Koning, et al.
World Journal of Urology|July 2, 2011
Biopsy and treatment decisions in the initial management of prostate cancer and the role of PCA3; a systematic analysis of expert opinionBertrand Tombal, Filip Ameye, Alexandre de la Taille, et al.
BJU International|August 29, 2018
Peri-operative and local control outcomes of robot-assisted partial nephrectomy vs percutaneous cryoablation for renal masses: comparison after matching on radiological stage and renal scoreGuillaume Fraisse, Loïc Colleter, Benoit Peyronnet, et al.
Cancer Letters|September 23, 2017
Extracellular vesicles released by mesenchymal-like prostate carcinoma cells modulate EMT state of recipient epithelial-like carcinoma cells through regulation of AR signalingIhsan Y El-Sayed, Ahmad Daher, Damien Destouches, et al.
BJU International|December 17, 2008
Cancer-specific and non-cancer-related mortality rates in European patients with T1a and T1b renal cell carcinomaLaurent Zini, Jean-Jacques Patard, Umberto Capitanio, et al.
BJU International|November 4, 2010
Transurethral plasma vaporization of the prostate: 3-month functional outcome and complicationsGrégoire Robert, Aurélien Descazeaud, Nicolas Barry Delongchamps, et al.
Life Science Alliance|November 17, 2019
Reference-free transcriptome exploration reveals novel RNAs for prostate cancer diagnosisMarina Pinskaya, Zohra Saci, Mélina Gallopin, et al.
Human Pathology|June 7, 2003
Evaluation of the interobserver reproducibility of Gleason grading of prostatic adenocarcinoma using tissue microarraysAlexandre De la Taille, Annick Viellefond, Nicole Berger, et al.
European Urology|April 7, 2007
Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1000 consecutive patientsGuillaume Guichard, Stéphane Larré, Andrea Gallina, et al.
Cancer Research|November 4, 2010
Class III beta-tubulin expression predicts prostate tumor aggressiveness and patient response to docetaxel-based chemotherapyGuillaume Ploussard, Stéphane Terry, Pascale Maillé, et al.
Pageof 36